AKT1 and breast cancer: According to a previous study, specific activation of AKT-1 is a contributor to EZH2-induced phenotype, and the overexpression of EZH2 induces activation of AKT-1 and BRCA1 inhibition in breast cancer,10 which was consistent with our findings.